Söndag 14 September | 13:24:34 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2025-11-27 11:00 Kvartalsrapport 2025-Q3
2025-08-28 - Kvartalsrapport 2025-Q2
2025-05-28 - Kvartalsrapport 2025-Q1
2025-05-09 - X-dag ordinarie utdelning POLAR 0.00 SEK
2025-05-08 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2025-02-20 - Extra Bolagsstämma 2024
2024-12-05 - Split POLAR 300:1
2024-11-29 - Kvartalsrapport 2024-Q3
2024-08-30 - Kvartalsrapport 2024-Q2
2024-05-31 - Kvartalsrapport 2024-Q1
2024-05-29 - X-dag ordinarie utdelning POLAR 0.00 SEK
2024-05-28 - Årsstämma
2024-02-23 - Bokslutskommuniké 2023
2023-11-24 - Kvartalsrapport 2023-Q3
2023-09-08 - Extra Bolagsstämma 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-26 - Kvartalsrapport 2023-Q1
2023-05-17 - Årsstämma
2023-05-05 - X-dag ordinarie utdelning POLAR 0.00 SEK
2023-03-13 - Extra Bolagsstämma 2022
2023-02-24 - Bokslutskommuniké 2022
2022-11-25 - Kvartalsrapport 2022-Q3
2022-08-26 - Kvartalsrapport 2022-Q2
2022-05-27 - Kvartalsrapport 2022-Q1
2022-05-06 - X-dag ordinarie utdelning POLAR 0.00 SEK
2022-05-05 - Årsstämma
2022-02-25 - Bokslutskommuniké 2021
2021-11-26 - Kvartalsrapport 2021-Q3
2021-08-27 - Kvartalsrapport 2021-Q2
2021-05-28 - Kvartalsrapport 2021-Q1
2021-05-06 - X-dag ordinarie utdelning POLAR 0.00 SEK
2021-05-05 - Årsstämma
2021-02-26 - Bokslutskommuniké 2020
2020-11-27 - Kvartalsrapport 2020-Q3
2020-08-28 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning POLAR 0.00 SEK
2020-06-30 - Årsstämma
2020-05-29 - Kvartalsrapport 2020-Q1
2020-02-28 - Bokslutskommuniké 2019
2020-02-14 - Extra Bolagsstämma 2020
2019-10-23 - Kvartalsrapport 2019-Q3
2019-07-24 - Kvartalsrapport 2019-Q2
2019-05-07 - Split POLAR 16:1
2019-04-26 - Kvartalsrapport 2019-Q1
2019-03-19 - Årsstämma
2019-02-04 - X-dag ordinarie utdelning POLAR 0.00 SEK
2019-02-01 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Polarcool är verksamt inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2025-09-04 10:01:00

PolarCool AB (publ.) has entered into a new two-year agreement with SHL club Malmö Redhawks for the use of PolarCap® in concussion treatment. Under the agreement, the Redhawks will integrate PolarCap® as a standardized part of their medical protocols for acute concussion management.

The Malmö Redhawks are committed to leading the way in player health and safety. By incorporating PolarCap®, the club further strengthens its proactive efforts to address the serious risks of head injuries faced by ice hockey players.

Malmö Redhawks Sport Director Oscar Alsenfelt comments:

-As the person with sporting responsibility for the organization, it is obvious to me that we must ensure our players receive the best possible care, especially when it comes to serious head injuries. The fact that we continue to enable our players to be treated with PolarCap® if they suffer a head injury is an important part of that work.

PolarCool CEO Erik Andersson comments:

-We are very pleased that Malmö Redhawks has signed a new agreement for PolarCap®. With this, the club shows with true action that it values the health of its players through the introduction of innovative medical solutions, and we view positively the continued growth of our presence in Swedish and European ice hockey

PolarCool develops the PolarCap®, which is used to alleviate the effects of concussions through early cooling. The primary customers are sports clubs and training facilities in contact sports such as ice hockey, rugby, football, and handball.

The agreement with Malmö Redhawks is strategically important for PolarCool as it further strengthens the company's position in European elite ice hockey and demonstrates that more clubs recognize the value of making the treatment available to their players.